Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1951 1
1953 1
1955 2
1958 2
1959 1
1960 1
1965 5
1966 9
1967 12
1968 13
1969 9
1970 31
1971 50
1972 49
1973 44
1974 61
1975 57
1976 65
1977 53
1978 48
1979 46
1980 53
1981 46
1982 74
1983 78
1984 92
1985 81
1986 81
1987 93
1988 71
1989 80
1990 89
1991 96
1992 82
1993 99
1994 85
1995 87
1996 117
1997 115
1998 131
1999 152
2000 130
2001 132
2002 154
2003 148
2004 133
2005 184
2006 177
2007 164
2008 175
2009 165
2010 182
2011 194
2012 192
2013 190
2014 186
2015 169
2016 168
2017 192
2018 214
2019 216
2020 236
2021 166
2022 168
2023 167
2024 87

Text availability

Article attribute

Article type

Publication date

Search Results

6,183 results

Results by year

Filters applied: . Clear all
Page 1
Complementary Therapies in Parkinson Disease: a Review of Acupuncture, Tai Chi, Qi Gong, Yoga, and Cannabis.
Deuel LM, Seeberger LC. Deuel LM, et al. Neurotherapeutics. 2020 Oct;17(4):1434-1455. doi: 10.1007/s13311-020-00900-y. Neurotherapeutics. 2020. PMID: 32785848 Free PMC article. Review.
Parkinson disease (PD) is a progressive neurodegenerative condition characterized by bradykinesia, rigidity, resting tremor, and postural instability. Non-motor symptoms, including pain, fatigue, insomnia, anxiety, and depression to name a few, are increasingly recognized …
Parkinson disease (PD) is a progressive neurodegenerative condition characterized by bradykinesia, rigidity, resting tremor, and post …
Current and future directions of deep brain stimulation for neurological and psychiatric disorders.
Lee DJ, Lozano CS, Dallapiazza RF, Lozano AM. Lee DJ, et al. J Neurosurg. 2019 Aug 1;131(2):333-342. doi: 10.3171/2019.4.JNS181761. J Neurosurg. 2019. PMID: 31370011 Review.
Although it has primarily been used to treat movement disorders such as Parkinson's disease, essential tremor, and dystonia, recently it has been approved to treat obsessive-compulsive disorder and epilepsy. ...There have been significant advances in DBS technology, includ …
Although it has primarily been used to treat movement disorders such as Parkinson's disease, essential tremor, and dystonia, recently …
Holding chambers (spacers) versus nebulisers for beta-agonist treatment of acute asthma.
Cates CJ, Welsh EJ, Rowe BH. Cates CJ, et al. Cochrane Database Syst Rev. 2013 Sep 13;2013(9):CD000052. doi: 10.1002/14651858.CD000052.pub3. Cochrane Database Syst Rev. 2013. PMID: 24037768 Free PMC article. Review.
Date of last search: February 2013. SELECTION CRITERIA: Randomised trials in adults and children (from two years of age) with asthma, where spacer beta(2)-agonist delivery was compared with wet nebulisation. ...Pulse rate was lower for spacer in children, mean difference - …
Date of last search: February 2013. SELECTION CRITERIA: Randomised trials in adults and children (from two years of age) with asthma, …
Pericyazine for schizophrenia.
Matar HE, Almerie MQ, Makhoul S, Xia J, Humphreys P. Matar HE, et al. Cochrane Database Syst Rev. 2014 May 13;2014(5):CD007479. doi: 10.1002/14651858.CD007479.pub2. Cochrane Database Syst Rev. 2014. PMID: 24825770 Free PMC article. Review.
We inspected references of all identified studies for further trials. SELECTION CRITERIA: All relevant randomised controlled trials focusing on pericyazine for schizophrenia and other types of schizophrenia-like psychoses (schizophreniform and schizoaffective disorders). W …
We inspected references of all identified studies for further trials. SELECTION CRITERIA: All relevant randomised controlled trials f …
Miglustat.
McCormack PL, Goa KL. McCormack PL, et al. Drugs. 2003;63(22):2427-34; discussion 2435-6. doi: 10.2165/00003495-200363220-00006. Drugs. 2003. PMID: 14609352 Review.
In an open extension phase, patients continued to show further reductions in organ volume as well as significant improvements in haematological parameters at 24 and 36 months. black triangle In a 6-month randomised study in patients with type 1 Gaucher's disease who had pr …
In an open extension phase, patients continued to show further reductions in organ volume as well as significant improvements in haematologi …
Therapeutic advances in tremor.
Fasano A, Deuschl G. Fasano A, et al. Mov Disord. 2015 Sep 15;30(11):1557-65. doi: 10.1002/mds.26383. Epub 2015 Aug 21. Mov Disord. 2015. PMID: 26293405 Review.
Further new invasive and noninvasive electrical and magnetic stimulation techniques have been tested for essential tremor and parkinsonian tremor. For multiple sclerosis tremor, some open-label observations have shown positive results (natalizumab, dalfamprid …
Further new invasive and noninvasive electrical and magnetic stimulation techniques have been tested for essential tremor and parkins …
FDA Approval: Blinatumomab.
Przepiorka D, Ko CW, Deisseroth A, Yancey CL, Candau-Chacon R, Chiu HJ, Gehrke BJ, Gomez-Broughton C, Kane RC, Kirshner S, Mehrotra N, Ricks TK, Schmiel D, Song P, Zhao P, Zhou Q, Farrell AT, Pazdur R. Przepiorka D, et al. Clin Cancer Res. 2015 Sep 15;21(18):4035-9. doi: 10.1158/1078-0432.CCR-15-0612. Clin Cancer Res. 2015. PMID: 26374073
Other common (>20%) adverse reactions were pyrexia, headache, edema, febrile neutropenia, nausea, tremor, and rash. Neutropenia, thrombocytopenia, and elevated transaminases were the most common (>10%) laboratory abnormalities related to blinatumomab. A randomized …
Other common (>20%) adverse reactions were pyrexia, headache, edema, febrile neutropenia, nausea, tremor, and rash. Neutropenia, t …
"N-Acetylcysteine for Obsessive-Compulsive and Related Disorders in Children and Adolescents: A Review".
Parli GM, Gales MA, Gales BJ. Parli GM, et al. Ann Pharmacother. 2023 Jul;57(7):847-854. doi: 10.1177/10600280221138092. Epub 2022 Nov 16. Ann Pharmacother. 2023. PMID: 36384314 Review.
OBJECTIVE: To evaluate clinical data using oral n-acetylcysteine (NAC) in obsessive-compulsive and related disorders (OCDRD) treatment. ...One trial in TTM found no difference between the NAC and placebo. Adverse effects were mild and included nausea, blurred vision …
OBJECTIVE: To evaluate clinical data using oral n-acetylcysteine (NAC) in obsessive-compulsive and related disorders (OCDRD) treatmen …
Lithium tremor.
Gelenberg AJ, Jefferson JW. Gelenberg AJ, et al. J Clin Psychiatry. 1995 Jul;56(7):283-7. J Clin Psychiatry. 1995. PMID: 7615481 Review.
METHOD: The data base of the Lithium Information Center in Madison, Wis., was searched for articles relating to lithium tremor. RESULTS: Studies show a wide range of incidence of lithium tremor--4% to 65%--due to differences in defining and reporting this side effec …
METHOD: The data base of the Lithium Information Center in Madison, Wis., was searched for articles relating to lithium tremor. RESUL …
Topiramate for essential tremor.
Bruno E, Nicoletti A, Quattrocchi G, Allegra R, Filippini G, Colosimo C, Zappia M. Bruno E, et al. Cochrane Database Syst Rev. 2017 Apr 14;4(4):CD009683. doi: 10.1002/14651858.CD009683.pub2. Cochrane Database Syst Rev. 2017. PMID: 28409827 Free PMC article. Review.
BACKGROUND: Essential tremor (ET) is one of the most common movement disorders. The management is primarily based on pharmacological agents and in clinical practice propranolol and primidone are considered the first-line therapy. ...We excluded studies conducted in …
BACKGROUND: Essential tremor (ET) is one of the most common movement disorders. The management is primarily based on pharmacological …
6,183 results